About Catalyst Regulatory Services
Catalyst Regulatory Services is a company based in Chelsea (United States) founded in 2012 by John P Balser and Barbara Balser was acquired by Veristat in December 2019. Catalyst Regulatory Services operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
- Headquarter Chelsea, United States
- Founders John P Balser, Barbara Balser
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Catalyst Regulatory Services
Detailed funding history for Catalyst Regulatory Services
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Catalyst Regulatory Services
Catalyst Regulatory Services has secured backing from 1 investor. Prominent investors backing the company include Veristat.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical trials and regulatory submissions are supported as a CRO.
|
Locked | Locked | Locked |
Investor details for Catalyst Regulatory Services
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Catalyst Regulatory Services
Investment portfolio details for Catalyst Regulatory Services
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Catalyst Regulatory Services
Detailed financials for Catalyst Regulatory Services
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Catalyst Regulatory Services Comparisons
Peer comparison for Catalyst Regulatory Services
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Catalyst Regulatory Services
Catalyst Regulatory Services operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
Detailed competitors of Catalyst Regulatory Services
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Catalyst Regulatory Services
Complete news archive for Catalyst Regulatory Services
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Catalyst Regulatory Services
Catalyst Regulatory Services was founded in 2012.
Catalyst Regulatory Services is headquartered in Chelsea, United States. It is registered at Chelsea, Massachusetts, United States.
Catalyst Regulatory Services was established in 2012 in Chelsea, United States, within the pharmaceutical sector. Drug designing, development, and consulting services are delivered to support regulatory needs. Operations focus on compliance and advisory roles for pharmaceutical projects. The company is led by co-founders John P. Balser as owner and Barbara Balser as chief scientific officer. Geographic emphasis remains on the U.S. market.
Catalyst Regulatory Services's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Catalyst Regulatory Services has 1 investor. Key investors include Veristat.